BTG3 and autoimmune hepatitis: Although autoimmune hepatitis was considered in the differential diagnosis, specific autoantibody testing (e.g., ANA, SMA, LKM1, anti‐SLA/LP) was not pursued due to the rapid normalization of liver enzymes following drug discontinuation and the absence of clinical features suggestive of chronic liver disease.